Naturland Holding Zrt (BUD:NATURLAND) Debt-to-Equity : 0.06 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Naturland Holding Zrt Debt-to-Equity?

Naturland Holding Zrt's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was Ft27 Mil. Naturland Holding Zrt's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was Ft160 Mil. Naturland Holding Zrt's Total Stockholders Equity for the quarter that ended in Dec. 2023 was Ft3,196 Mil. Naturland Holding Zrt's debt to equity for the quarter that ended in Dec. 2023 was 0.06.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Naturland Holding Zrt's Debt-to-Equity or its related term are showing as below:

BUD:NATURLAND' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.06 Med: 0.11 Max: 0.16
Current: 0.06

During the past 4 years, the highest Debt-to-Equity Ratio of Naturland Holding Zrt was 0.16. The lowest was 0.06. And the median was 0.11.

BUD:NATURLAND's Debt-to-Equity is ranked better than
78.79% of 844 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs BUD:NATURLAND: 0.06

Naturland Holding Zrt Debt-to-Equity Historical Data

The historical data trend for Naturland Holding Zrt's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Naturland Holding Zrt Debt-to-Equity Chart

Naturland Holding Zrt Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

0.16

0.11

0.06

Naturland Holding Zrt Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial			0.16	N/A	0.11	0.10	0.06

Competitive Comparison of Naturland Holding Zrt's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Naturland Holding Zrt's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Naturland Holding Zrt's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Naturland Holding Zrt's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Naturland Holding Zrt's Debt-to-Equity falls into.

Naturland Holding Zrt Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Naturland Holding Zrt's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(26.801	+	159.904)	/	3195.603
	=	0.06

Naturland Holding Zrt's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(26.801	+	159.904)	/	3195.603
	=	0.06

Naturland Holding Zrt (BUD:NATURLAND) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Naturland Holding Zrt Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Naturland Holding Zrt's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Naturland Holding Zrt (BUD:NATURLAND) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Naturland Holding Zrt (BUD:NATURLAND) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Csillagvirag utca 8, Budapest, HUN, 1106

Website

https://www.naturlandholding.hu

Naturland Holding Zrt thro9ugh its subsidiaries engage in the production of pharmaceutical products. It engages in the development, production, and wholesale of dietary supplements and cosmetics, herbal medicine, teas, and essential oils. The firm offers tablets, suppositories, ointments, and ophthalmic base solutions.

Naturland Holding Zrt (BUD:NATURLAND) Headlines

No Headlines